HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sunil Badve Selected Research

Nut Proteins

12/2014NUT midline carcinomas in the thymic region.
9/2013NUT protein is not expressed in undifferentiated (anaplastic) thyroid carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sunil Badve Research Topics

Disease

83Neoplasms (Cancer)
04/2022 - 12/2002
80Breast Neoplasms (Breast Cancer)
04/2022 - 01/2002
21Neoplasm Metastasis (Metastasis)
04/2022 - 12/2003
9Carcinoma (Carcinomatosis)
06/2018 - 01/2002
8Triple Negative Breast Neoplasms
01/2022 - 11/2011
8Noninfiltrating Intraductal Carcinoma (DCIS)
10/2019 - 02/2003
7Thymoma (Thymic Carcinoma)
12/2018 - 05/2010
4Adenocarcinoma
04/2009 - 09/2002
3Disease Progression
10/2021 - 04/2009
3Residual Neoplasm
01/2020 - 02/2003
2Obesity
01/2020 - 01/2008
2Brain Neoplasms (Brain Tumor)
11/2017 - 07/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017 - 12/2010
2Lobular Carcinoma
07/2013 - 11/2005
2Seminoma
10/2010 - 10/2007
2Ductal Carcinoma
11/2005 - 02/2003
1Pathologic Complete Response
10/2021
1Diabetes Mellitus
01/2020
1Circulating Neoplastic Cells
01/2020
1Margins of Excision
07/2019
1Autoimmune Diseases (Autoimmune Disease)
12/2018
1Myasthenia Gravis
12/2018
1Aneuploidy (Aneuploid)
12/2018
1Carcinoma in Situ
10/2018
1Melanoma (Melanoma, Malignant)
11/2017
1Mesothelioma
11/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017
1Extranodal Extension
09/2017
1Thrombocytopenia (Thrombopenia)
08/2017

Drug/Important Bio-Agent (IBA)

27Estrogen ReceptorsIBA
04/2022 - 12/2002
25Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2003
12Hormones (Hormone)IBA
10/2021 - 04/2007
11Phenobarbital (Luminal)FDA Link
01/2017 - 04/2007
10Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 12/2002
10RNA (Ribonucleic Acid)IBA
12/2019 - 05/2005
10Estrogens (Estrogen)FDA Link
01/2016 - 12/2002
10Proteins (Proteins, Gene)FDA Link
07/2013 - 01/2002
7DNA (Deoxyribonucleic Acid)IBA
09/2015 - 04/2006
6human ERBB2 proteinIBA
10/2021 - 12/2009
6ParaffinIBA
12/2019 - 11/2005
6Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019 - 01/2005
6Biological ProductsIBA
12/2018 - 01/2004
6Estrogen Receptor alphaIBA
01/2016 - 04/2007
6Phosphotransferases (Kinase)IBA
01/2013 - 05/2005
5Messenger RNA (mRNA)IBA
12/2016 - 11/2002
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 01/2006
5TamoxifenFDA LinkGeneric
05/2013 - 12/2002
5Transcription Factors (Transcription Factor)IBA
01/2010 - 06/2005
4Trastuzumab (Herceptin)FDA Link
01/2022 - 03/2015
4Formaldehyde (Formol)FDA Link
12/2019 - 04/2009
3Immune Checkpoint InhibitorsIBA
12/2021 - 10/2016
3Hematoxylin (Haematoxylon)IBA
10/2019 - 06/2014
3Eosine Yellowish-(YS) (Eosin)IBA
10/2019 - 06/2014
3AnthracyclinesIBA
08/2017 - 12/2009
3CytokinesIBA
05/2015 - 12/2003
3Small Interfering RNA (siRNA)IBA
07/2014 - 03/2006
3Cadherins (E-Cadherin)IBA
07/2013 - 05/2003
3Docetaxel (Taxotere)FDA Link
06/2007 - 01/2005
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2019 - 08/2017
2Keratins (Keratin)IBA
01/2019 - 07/2010
2Epidermal Growth Factor (EGF)IBA
03/2016 - 11/2010
2Pharmaceutical PreparationsIBA
05/2015 - 12/2007
2Nut ProteinsIBA
12/2014 - 09/2013
2Bevacizumab (Avastin)FDA Link
01/2014 - 10/2008
2AntibodiesIBA
07/2013 - 09/2002
2Estradiol (Delestrogen)FDA LinkGeneric
05/2010 - 06/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2010 - 12/2003
2Insulin (Novolin)FDA Link
01/2010 - 01/2008
2CarcinogensIBA
11/2009 - 06/2008
2Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2007 - 12/2006
2Protein Isoforms (Isoforms)IBA
01/2007 - 12/2006
1RS 20IBA
04/2022
1Capecitabine (Xeloda)FDA Link
01/2022
1beta-2 Adrenergic ReceptorsIBA
01/2022
1gedatolisibIBA
01/2022
1cofetuzumab pelidotinIBA
01/2022
1B7-H1 AntigenIBA
12/2021
1Circulating Tumor DNAIBA
01/2020
1neratinibIBA
01/2020
1atezolizumabIBA
01/2020
1pertuzumabIBA
01/2020
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Icodextrin (Extraneal)FDA Link
01/2020
1Lapatinib (GW572016)FDA Link
01/2020
1130-nm albumin-bound paclitaxelIBA
01/2020
1LipidsIBA
01/2019
1B 31IBA
01/2019
1AutoantigensIBA
12/2018
1amrubicinIBA
08/2017

Therapy/Procedure

31Therapeutics
01/2022 - 01/2006
14Drug Therapy (Chemotherapy)
04/2022 - 01/2005
5Neoadjuvant Therapy
01/2022 - 05/2012
4Adjuvant Chemotherapy
04/2022 - 12/2009
3Radiotherapy
10/2019 - 07/2012
2Mastectomy (Mammectomy)
07/2019 - 03/2003
2Aftercare (After-Treatment)
09/2015 - 12/2008
2Precision Medicine
06/2014 - 03/2011
1Kidney Transplantation
01/2020
1Immunotherapy
11/2017